Exchange: NYSE·Updated 07:30 PM EDT

TFX News

News
all
press releases
Teleflex Announces FDA Breakthrough Device Designation for Freesolve Resorbable Magnesium Scaffold
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) for its Freesolve Resorbable Magnesium Scaffold (RMS) for percutaneous coronary intervention...
Business Wire
Teleflex Announces FDA Breakthrough Device Designation for Freesolve Resorbable Magnesium Scaffold
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) for its Freesolve Resorbable Magnesium Scaffold (RMS) for percutaneous coronary intervention...
Business Wire
More News
Teleflex Announces Third Quarter 2026 Earnings Conference Call Information
Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, November 5, 2026. To participate in the conference call, please utilize this link to pre-register and receive the...
Business Wire
Natera Gains 118.1% in a Year: What's Driving the Rally?
NTRA shares surge 118.1% in a year, fueled by robust Signatera adoption, expanding test volumes and improving margins, despite competition and rising costs.
Zacks
Enrollment Completed in BIOMAG-LL Clinical Study Evaluating Longer Lengths for Freesolve Resorbable Magnesium Scaffold
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the successful completion of patient enrollment in the BIOMAG-LL Clinical Study, evaluating the safety and clinical performance of the Freesolve Resorbable Magnesium Scaffold (RMS) in 35 mm and 40...
Business Wire
Bruker Gains 66.3% in a Year: What's Driving the Rally?
BRKR shares surge 66.3% in a year, fueled by strong demand in mass spectrometry and biopharma, despite restructuring challenges and currency headwinds.
Zacks
Reasons to Add Globus Medical Stock to Your Portfolio Now
GMED gains musculoskeletal share on strong spine and trauma growth, while product innovation and a debt-free balance sheet support its appeal.
Zacks
Charles River Gains 75.8% in a Year: What's Driving the Rally?
CRL shares have surged 75.8% in a year as RMS trends improve, AI-enabled testing expands and cash flow supports buybacks and investment.
Zacks
TFX or SONVY: Which Is the Better Value Stock Right Now?
TFX vs. SONVY: Which Stock Is the Better Value Option?
Zacks
Is It Prudent to Add Teleflex Stock to Your Portfolio Now?
TFX's Vascular growth, Asia expansion and improved leverage support the outlook, but tariffs, input costs and margin pressure remain key risks.
Zacks
Boston Scientific's MedSurg Diversification Bolsters Growth Prospects
BSX's MedSurg segment supports growth, with Endoscopy and Neuromodulation gains offsetting Urology challenges and portfolio gaps.
Zacks

Advertisement|Remove ads.